(Biomedical Advanced Research and Development Authority) Provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as pandemic influenza or emerging infectious diseases, and national health security such as chemical, biological, radiological nuclear accidents, incidents and attacks. This is a larger NIH funding vehicle; an indirect rate must be negotiated.
- May 7, 2018
- Jameson & Company
Subscribe for Updates
Featured White Paper
Video: How to Project an Indirect Rate
Accounting audit BAA Contracts CPA DCAA DCAA audits Defense Federal Acquisition Regulation (DFAR) Department of Defense dfas DoD F & A rate F&A rates FAR compliance FAR compliant accounting system FAR part 31 Federal Acquisition Regulations Fringe rate government award accounting government award accounting system government award audit grant Grants Indirect cost rate Indirect Rates JamesonWorx Multiplier NIH NIH grants NIH Grants Policy Statement omb a-133 Payment Management System Phase II SBIR funding Quickbooks r01 SBIR SBIR Accounting SBIR Phase I SBIR Phase II SF-425 Small business STTR UGA Uncompensated Overtime Uniform Guidance Audit